This is unpublished
Bridging the gap between cancer drug target and cancer drug
Fred Hutch RNA-translation expert Dr. Andrew Hsieh receives Harrington Scholar-Innovator Award to develop experimental compound into anti-cancer drug
RADIANT: Enhancing Diversity in Cancer Clinical Trials
Dr. Shaveta Vinayak leads the RADIANT program, a new initiative aimed to increase diversity among participants of cancer clinical trials.
Benjamin Lidgard joins 2024 cohort of KL2 scholars
His research focuses on lipid molecule metabolism as a cardiovascular risk factor in patients with kidney disease.